Table 3. Disposition of confirmed adverse events in patients prescribed anti-dementia drugs (n = 863) (Multiple answers possible).
| Male | Female | Overall | ||||
|---|---|---|---|---|---|---|
| Adverse Reactions | %a | Present, N | %a | Present, N | %a | |
| Overall | 43 | 122 | 170b | |||
| Excitement/insomnia | 23 | 57.5 | 48 | 40.3 | 74 | 45.1 |
| Nausea/vomiting/diarrhea | 12 | 30.0 | 43 | 36.1 | 55 | 33.5 |
| Hallucination/delusion/visual hallucination | 14 | 35.0 | 20 | 16.8 | 35 | 21.3 |
| Poriomania/violent behavior | 6 | 15.0 | 18 | 15.1 | 26 | 15.9 |
| Patch-induced rash | 6 | 15.0 | 10 | 8.4 | 17 | 10.4 |
| Parkinson’s-like symptoms | 6 | 15.0 | 8 | 6.7 | 14 | 8.5 |
| Pollakiuria/incontinence | 7 | 17.5 | 5 | 4.2 | 12 | 7.3 |
| Dizziness | 0 | 0.0 | 8 | 6.7 | 8 | 4.9 |
| Bradycardia/arrhythmia | 3 | 7.5 | 2 | 1.7 | 5 | 3.0 |
| Other | 2 | 5.0 | 5 | 4.2 | 7 | 4.3 |
a: Excluding subjects from whom responses were not obtained
b: Including 5 subjects whose sex was unknown